Description

Join us as we review the latest cellular therapy advancements for treatment in the COVID-19 pandemic. In addition to addressing the use of specific T cells in COVID-19 treatment, faculty will also discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis.

Learning Objectives:

• Discuss the latest cellular therapies advancements in the COVID-19 pandemic
• Investigate the use of specific T cells in COVID-19 treatment
• Discuss the importance of missing imputation for single cell sequencing (MISC) in COVID-19 analysis

Speaker(s):

• Dusan Bogunovic, Icahn School of Medicine
• Dr. Michael Keller, Childrens' National

Disclosures

• Dusan Bogunovic : Nothing to disclose
• Michael Keller : Consultant: Gilead